Stránka 184


PříspěvekNapsal: 09 lis 2015 09:22
od Petr75
Pomocí překladače, vyhledávače si najdete výzkum co Vás může zajímat..

2015 Listopad 01

This message contains My NCBI what's new results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).

2. Differences in the burden of psychiatric comorbidity in MS vs the general population.
Marrie RA, Fisk JD, Tremlett H, Wolfson C, Warren S, Tennakoon A, Leung S, Patten SB; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis.
Neurology. 2015 Oct 30. pii: 10.1212/WNL.0000000000002174. [Epub ahead of print]
PMID: 26519542 [PubMed - as supplied by publisher]
Similar articles
3. MyelStones: the executive roles of myelin basic protein in myelin assembly and destabilization in multiple sclerosis.
Vassall KA, Bamm VV, Harauz G.
Biochem J. 2015 Nov 15;472(1):17-32. doi: 10.1042/BJ20150710. Review.
PMID: 26518750 [PubMed - in process]
Similar articles
4. Validation of a Dutch version of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: an observational web-based study.
Jongen PJ, Blok BF, Heesakkers JP, Heerings M, Lemmens WA, Donders R.
Health Qual Life Outcomes. 2015 Oct 30;13(1):175.
PMID: 26518712 [PubMed - as supplied by publisher]
Similar articles
5. Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection.
Mowry EM, Pelletier D, Gao Z, Howell MD, Zamvil SS, Waubant E.
Eur J Neurol. 2015 Oct 31. doi: 10.1111/ene.12844. [Epub ahead of print]
PMID: 26518224 [PubMed - as supplied by publisher]
Similar articles
6. Tribbles and arthritis: what are the links?
Rowan AD, Litherland GJ.
Biochem Soc Trans. 2015 Oct 1;43(5):1051-6. doi: 10.1042/BST20150076. Review.
PMID: 26517922 [PubMed - in process]
Similar articles
7. Intrathecal Baclofen Dosing Regimens: A Retrospective Chart Review.
Clearfield JS, Nelson ME, McGuire J, Rein LE, Tarima S.
Neuromodulation. 2015 Oct 30. doi: 10.1111/ner.12361. [Epub ahead of print]
PMID: 26517855 [PubMed - as supplied by publisher]
Similar articles
8. Progressive multifocal leukoencephalopathy associated to natalizumab extended dosing regimen.
Hervás JV, Presas-Rodríguez S, Crespo-Cuevas AM, Canento T, Lozano-Sánchez M, Massuet-Vilamajó A, Ramo-Tello C.
Neurodegener Dis Manag. 2015 Oct 30. [Epub ahead of print]
PMID: 26517599 [PubMed - as supplied by publisher]
Similar articles
9. Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS.
Kim SM, Woodhall MR, Kim JS, Kim SJ, Park KS, Vincent A, Lee KW, Waters P.
Neurol Neuroimmunol Neuroinflamm. 2015 Oct 15;2(6):e163. doi: 10.1212/NXI.0000000000000163. eCollection 2015 Dec.
PMID: 26516628 [PubMed]
Similar articles
10. Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis.
Bove R, White CC, Giovannoni G, Glanz B, Golubchikov V, Hujol J, Jennings C, Langdon D, Lee M, Legedza A, Paskavitz J, Prasad S, Richert J, Robbins A, Roberts S, Weiner H, Ramachandran R, Botfield M, De Jager PL.
Neurol Neuroimmunol Neuroinflamm. 2015 Oct 15;2(6):e162. doi: 10.1212/NXI.0000000000000162. eCollection 2015 Dec.
PMID: 26516627 [PubMed]
Similar articles
11. FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib-mediated cytotoxicity.
Ahmed D, de Verdier PJ, Ryk C, Lunqe O, Stål P, Flygare J.
Pharmacol Res Perspect. 2015 Oct;3(5):e00171. doi: 10.1002/prp2.171. Epub 2015 Aug 19.
PMID: 26516583 [PubMed]
Similar articles
12. Evaluation of the Degradation of the Selected Projectile, Commissural and Association White Matter Tracts Within Normal Appearing White Matter in Patients with Multiple Sclerosis Using Diffusion Tensor MR Imaging - a Preliminary Study.
Banaszek A, Bladowska J, Pokryszko-Dragan A, Podemski R, Sąsiadek MJ.
Pol J Radiol. 2015 Oct 5;80:457-63. doi: 10.12659/PJR.894661. eCollection 2015.
PMID: 26516389 [PubMed]
Similar articles
13. Liver Damage and Mortality in a Male Lewis Rat of Experimental Autoimmune Encephalomyelitis.
Ghaffarinia A, Jalili C, Mostafaie A, Parvaneh S, Pakravan N.
Iran J Pathol. 2015 Winter;10(1):9-16.
PMID: 26516320 [PubMed]
Similar articles
14. Marijuana Legalization: Impact on Physicians and Public Health.
Wilkinson ST, Yarnell S, Radhakrishnan R, Ball SA, D'Souza DC.
Annu Rev Med. 2015 Oct 19. [Epub ahead of print]
PMID: 26515984 [PubMed - as supplied by publisher]
Similar articles
15. The molecular physiology of the axo-myelinic synapse.
Micu I, Plemel JR, Lachance C, Proft J, Jansen AJ, Cummins K, van Minnen J, Stys PK.
Exp Neurol. 2015 Oct 26. pii: S0014-4886(15)30107-2. doi: 10.1016/j.expneurol.2015.10.006. [Epub ahead of print]
PMID: 26515690 [PubMed - as supplied by publisher]
Similar articles

18. S100A12 and the S100/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets.
Oesterle A, Bowman MA.
Arterioscler Thromb Vasc Biol. 2015 Oct 29. pii: ATVBAHA.115.302072. [Epub ahead of print]
PMID: 26515415 [PubMed - as supplied by publisher]
Similar articles
19. Neurodegeneration in multiple sclerosis is a process separate from inflammation: No.
Hutchinson M.
Mult Scler. 2015 Nov;21(13):1628-31. doi: 10.1177/1352458515612244. No abstract available.
PMID: 26515290 [PubMed - in process]
Similar articles
20. Neurodegeneration in multiple sclerosis is a process separate from inflammation: Yes.
Louapre C, Lubetzki C.
Mult Scler. 2015 Nov;21(13):1626-8. doi: 10.1177/1352458515587598. No abstract available.
PMID: 26515289 [PubMed - in process]
Similar articles

Re: PubMed

PříspěvekNapsal: 09 lis 2015 09:24
od Petr75
2015 Listopad 02

1. Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.
Keller A, Leidinger P, Meese E, Haas J, Backes C, Rasche L, Behrens JR, Pfuhl C, Wakonig K, Gieß RM, Jarius S, Meder B, Bellmann-Strobl J, Paul F, Pache FC, Ruprecht K.
J Neuroinflammation. 2015 Oct 31;12(1):196.
PMID: 26521232 [PubMed - as supplied by publisher]

2. Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammation.
Mossakowski AA, Pohlan J, Bremer D, Lindquist R, Millward JM, Bock M, Pollok K, Mothes R, Viohl L, Radbruch M, Gerhard J, Bellmann-Strobl J, Behrens J, Infante-Duarte C, Mähler A, Boschmann M, Rinnenthal JL, Füchtemeier M, Herz J, Pache FC, Bardua M, Priller J, Hauser AE, Paul F, Niesner R, Radbruch H.
Acta Neuropathol. 2015 Oct 31. [Epub ahead of print]
PMID: 26521072 [PubMed - as supplied by publisher]

3. The nod-like receptor, Nlrp12, plays an anti-inflammatory role in experimental autoimmune encephalomyelitis.
Gharagozloo M, Mahvelati TM, Imbeault E, Gris P, Zerif E, Bobbala D, Ilangumaran S, Amrani A, Gris D.
J Neuroinflammation. 2015 Oct 31;12(1):198.
PMID: 26521018 [PubMed - as supplied by publisher]

4. Pathobiology of tobacco smoking and neurovascular disorders: untied strings and alternative products.
Naik P, Cucullo L.
Fluids Barriers CNS. 2015 Oct 31;12(1):25.
PMID: 26520792 [PubMed - as supplied by publisher]

Re: PubMed

PříspěvekNapsal: 09 lis 2015 09:28
od Petr75
2015 Listopad 05

1. Correction: Increased Perfusion in Normal Appearing White Matter in High Inflammatory Multiple Sclerosis Patients.
Bester M, Forkert ND, Stellmann JP, Stürner K, Aly L, Drabik A, Young KL, Heesen C, Fiehler J, Siemonsen S.
PLoS One. 2015 Nov 4;10(11):e0142464. doi: 10.1371/journal.pone.0142464. eCollection 2015.
PMID: 26536669 [PubMed - as supplied by publisher]

2. Laquinimod (ABR-215062) for the treatment of relapsing multiple sclerosis.
Constantinescu SE, Constantinescu CS.
Expert Rev Clin Pharmacol. 2015 Nov 4:1-9. [Epub ahead of print]
PMID: 26536299 [PubMed - as supplied by publisher]

3. A Breakthrough Diagnosis.
Murray SG, Wachter RM, Cho KC, Dhaliwal G.
N Engl J Med. 2015 Nov 5;373(19):1865-1870.
PMID: 26535516 [PubMed - as supplied by publisher]

4. [There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis].
Bazinski H, Jensen HB, Stenager E.
Ugeskr Laeger. 2015 May 11;177(20):956-60. Danish.
PMID: 26535431 [PubMed - in process]

5. Do coping styles mediate the relationship between disability status and psychosocial loss in people with relapsing remitting multiple sclerosis?
Gedik Z, Sorias O, Idiman E.
J Health Psychol. 2015 Nov 3. pii: 1359105315611958. [Epub ahead of print]
PMID: 26534918 [PubMed - as supplied by publisher]

Re: PubMed

PříspěvekNapsal: 09 lis 2015 09:35
od Petr75
2015 Listopad 06

1. Why does multiple sclerosis only affect human primates?
't Hart BA.
Mult Scler. 2015 Jun 25. pii: 1352458515591862. [Epub ahead of print]
PMID: 26540733 [PubMed - as supplied by publisher]

2. Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapses.
Ramo-Tello C, Tintoré M, Rovira A, Ramió-Torrenta L, Brieva L, Saiz A, Cano A, Carmona O, Hervás JV, Grau-López L.
Mult Scler. 2015 Jun 25. pii: 1352458515590648. [Epub ahead of print]
PMID: 26540732 [PubMed - as supplied by publisher]

3. Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica.
Hertwig L, Pache F, Romero-Suarez S, Stürner KH, Borisow N, Behrens J, Bellmann-Strobl J, Seeger B, Asselborn N, Ruprecht K, Millward JM, Infante-Duarte C, Paul F.
Mult Scler. 2015 Jun 25. pii: 1352458515586084. [Epub ahead of print]
PMID: 26540731 [PubMed - as supplied by publisher]

4. Discovering Gene Regulatory Elements Using Coverage-based Heuristics.
Al-Ouran R, Schmidt R, Naik A, Jones J, Drews F, Juedes D, Elnitski L, Welch L.
IEEE/ACM Trans Comput Biol Bioinform. 2015 Oct 30. [Epub ahead of print]
PMID: 26540692 [PubMed - as supplied by publisher]

5. Epidemiology and molecular mechanism of frontotemporal lobar degeneration/amyotrophic lateral sclerosis with repeat expansion mutation in C9orf72.
Ishiura H, Tsuji S.
J Neurogenet. 2015 Jun-Sep;29(2-3):85-94.
PMID: 26540641 [PubMed - as supplied by publisher]

6. The Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from Kuwait.
Al-Temaimi RA, Al-Enezi A, Al-Serri A, Al-Roughani R, Al-Mulla F.
PLoS One. 2015 Nov 5;10(11):e0142265. doi: 10.1371/journal.pone.0142265. eCollection 2015.
PMID: 26540116 [PubMed - as supplied by publisher]

7. Serum sickness reaction with skin involvement induced by bee venom injection therapy.
Seo HJ, Lee J.
Asia Pac Allergy. 2015 Oct;5(4):230-3. doi: 10.5415/apallergy.2015.5.4.230. Epub 2015 Oct 28.
PMID: 26539406 [PubMed]

8. Infection as an Environmental Trigger of Multiple Sclerosis Disease Exacerbation.
Steelman AJ.
Front Immunol. 2015 Oct 19;6:520. doi: 10.3389/fimmu.2015.00520. eCollection 2015. Review.
PMID: 26539193 [PubMed]

9. Statistical image analysis of longitudinal RAVENS images.
Lee S, Zipunnikov V, Reich DS, Pham DL.
Front Neurosci. 2015 Oct 20;9:368. doi: 10.3389/fnins.2015.00368. eCollection 2015.
PMID: 26539071 [PubMed]

10. Epidemiology and genetic aspects of multiple sclerosis in India.
Bhatia R, Bali P, Chaudhari RM.
Ann Indian Acad Neurol. 2015 Sep;18(Suppl 1):S6-S10. doi: 10.4103/0972-2327.164814. Review.
PMID: 26538851 [PubMed]

11. Acquired demyelinating disorders of central nervous system: A pediatric cohort.
Gulati S, Chakrabarty B, Kumar A, Jain P, Patel H, Saini L.
Ann Indian Acad Neurol. 2015 Sep;18(Suppl 1):S48-55. doi: 10.4103/0972-2327.164829.
PMID: 26538849 [PubMed]

12. Rehabilitation of multiple sclerosis patients in India.
Surya N.
Ann Indian Acad Neurol. 2015 Sep;18(Suppl 1):S43-7. doi: 10.4103/0972-2327.164828. Review.
PMID: 26538848 [PubMed]

13. Symptomatic management in multiple sclerosis.
Shah P.
Ann Indian Acad Neurol. 2015 Sep;18(Suppl 1):S35-42. doi: 10.4103/0972-2327.164827. Review.
PMID: 26538847 [PubMed]

14. Newer therapies for multiple sclerosis.
Coles A.
Ann Indian Acad Neurol. 2015 Sep;18(Suppl 1):S30-4. doi: 10.4103/0972-2327.164824. Review.
PMID: 26538846 [PubMed]

15. Systematic imaging review: Multiple Sclerosis.
Katdare A, Ursekar M.
Ann Indian Acad Neurol. 2015 Sep;18(Suppl 1):S24-9. doi: 10.4103/0972-2327.164821. Review.
PMID: 26538845 [PubMed]

16. Multiple sclerosis in India: An overview.
Singhal BS, Advani H.
Ann Indian Acad Neurol. 2015 Sep;18(Suppl 1):S2-5. doi: 10.4103/0972-2327.164812. Review.
PMID: 26538844 [PubMed]

17. Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases.
Brkic M, Balusu S, Libert C, Vandenbroucke RE.
Mediators Inflamm. 2015;2015:620581. doi: 10.1155/2015/620581. Epub 2015 Oct 11. Review.
PMID: 26538832 [PubMed - in process]

18. Marine Diterpenoids as Potential Anti-Inflammatory Agents.
González Y, Torres-Mendoza D, Jones GE, Fernandez PL.
Mediators Inflamm. 2015;2015:263543. doi: 10.1155/2015/263543. Epub 2015 Oct 11. Review.
PMID: 26538822 [PubMed - in process]

19. A Disproportionate Burden of Care: Gender Differences in Mental Health, Health-Related Quality of Life, and Social Support in Mexican Multiple Sclerosis Caregivers.
Perrin PB, Panyavin I, Morlett Paredes A, Aguayo A, Macias MA, Rabago B, Picot SJ, Arango-Lasprilla JC.
Behav Neurol. 2015;2015:283958. doi: 10.1155/2015/283958. Epub 2015 Oct 11.
PMID: 26538818 [PubMed - in process]

20. Progesterone Enhanced Remyelination in the Mouse Corpus Callosum after Cuprizone Induced Demyelination.
Kashani IR PhD, Hedayatpour A PhD, Pasbakhsh P PhD, Kafami L PhD, Khallaghi B MSc, Malek F MSc.
Iran J Med Sci. 2015 Nov;40(6):507-514.
PMID: 26538779 [PubMed - as supplied by publisher]

Re: PubMed

PříspěvekNapsal: 09 lis 2015 09:42
od Petr75
2015 Listopad 07

1. Facial hypersensitivity and trigeminal pathology in mice with experimental autoimmune encephalomyelitis (EAE).
Thorburn KC, Paylor JW, Webber CA, Winship IR, Kerr BJ.
Pain. 2015 Nov 5. [Epub ahead of print]
PMID: 26545087 [PubMed - as supplied by publisher]

2. A subtle case of tuberous sclerosis complex.
Nakano H, Otsuka A, Kinoshita M.
Epilepsy Behav Case Rep. 2015 Sep 26;4:88-90. doi: 10.1016/j.ebcr.2015.08.002. eCollection 2015.
PMID: 26543814 [PubMed]

3. Use of the mTOR inhibitor everolimus in a patient with multiple manifestations of tuberous sclerosis complex including epilepsy.
Wheless JW.
Epilepsy Behav Case Rep. 2015 Aug 12;4:63-6. doi: 10.1016/j.ebcr.2015.06.008. eCollection 2015.
PMID: 26543807 [PubMed]

4. The Role of 3-O-Sulfogalactosylceramide, Sulfatide, in the Lateral Organization of Myelin Membrane.
Grassi S, Prioni S, Cabitta L, Aureli M, Sonnino S, Prinetti A.
Neurochem Res. 2015 Nov 5. [Epub ahead of print]
PMID: 26542149 [PubMed - as supplied by publisher]

5. Immunogenicity evaluation strategy for a second-generation therapeutic, PEG-IFN-β-1a.
White JT, Crossman M, Richter K, Berman M, Goyal J, Subramanyam M.
Bioanalysis. 2015 Nov 6. [Epub ahead of print]
PMID: 26541956 [PubMed - as supplied by publisher]

6. The Natural Dual Cyclooxygenase and 5-Lipoxygenase Inhibitor Flavocoxid is Protective in EAE Through Effects on Th1/Th17 Differentiation and Macrophage/Microglia Activation.
Kong W, Hooper KM, Ganea D.
Brain Behav Immun. 2015 Nov 2. pii: S0889-1591(15)30047-7. doi: 10.1016/j.bbi.2015.11.002. [Epub ahead of print]
PMID: 26541818 [PubMed - as supplied by publisher]

7. Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients.
Bergsland N, Zivadinov R, Dwyer MG, Weinstock-Guttman B, Benedict RH.
Mult Scler. 2015 Nov 5. pii: 1352458515616204. [Epub ahead of print]
PMID: 26541795 [PubMed - as supplied by publisher]

8. Asymptomatic progressive multifocal leukoencephalopathy during natalizumab therapy with treatment.
Fabis-Pedrini MJ, Xu W, Burton J, Carroll WM, Kermode AG.
J Clin Neurosci. 2015 Nov 2. pii: S0967-5868(15)00517-2. doi: 10.1016/j.jocn.2015.08.027. [Epub ahead of print]
PMID: 26541323 [PubMed - as supplied by publisher]

Re: PubMed

PříspěvekNapsal: 09 lis 2015 09:45
od Petr75
2015 Listopad 08

1. Oligodendrocyte Progenitor Programming and Reprogramming: Toward Myelin Regeneration.
Lopez Juarez A, He D, Richard Lu Q.
Brain Res. 2015 Nov 4. pii: S0006-8993(15)00822-7. doi: 10.1016/j.brainres.2015.10.051. [Epub ahead of print] Review.
PMID: 26546966 [PubMed - as supplied by publisher]
Similar articles
2. Evaluation of Soluble Human Leukocyte Antigen-G (sHLA-G) Isoforms and Regulatory T Cells in Relapsing-Remitting Multiple Sclerosis.
Alsahebfosoul F, Zavaran-Hosseini A, Salehi R, Etemadifar M, Esmaeil N, Jamshidian A.
Iran J Allergy Asthma Immunol. 2015 Jun;14(3):298-305.
PMID: 26546899 [PubMed - as supplied by publisher]
Similar articles
3. Untargeted plasma metabolomics identifies endogenous metabolite with drug-like properties in chronic animal model of multiple sclerosis.
Poisson LM, Suhail H, Singh J, Datta I, Denic A, Labuzek K, Hoda MN, Shankar A, Kumar A, Cerghet M, Elias S, Mohney RP, Rodriguez M, Rattan R, Mangalam AK, Giri S.
J Biol Chem. 2015 Nov 6. pii: jbc.M115.679068. [Epub ahead of print]
PMID: 26546682 [PubMed - as supplied by publisher]
Similar articles

Re: PubMed

PříspěvekNapsal: 09 lis 2015 20:53
od vychodocech
Petře, tento příspěvek jsem ale vůbec nepochopil, co s tím že máme dělat? Bez odkazu to zde takto nechat nemůžeme, musíme vědět co s tím.

Re: PubMed

PříspěvekNapsal: 09 lis 2015 22:39
od Franta
to je fakt, maximálně to přesunout do anglických článků bez překladu.
I když je toto fórum zaměřené na vývoj a výzkum, tak je určené primárně pro laickou veřejnost a pacienty, kteří se chtějí dozvědět víc než jen to co se dozví v ordinaci.
Aby si tu členové fóra četli vědecké články v angličtině, tak to už by jsme chtěli asi moc.
Vědecké články bývají často nezajímavé, například o nějakých genetických faktorech v Indii. A nebo několikastránkové články pro mě jako pro laika, i když s určitým rozhledem by překlad do češtiny zabral dost času a některé z nich často používají mnoho vědeckých termínů pro analytické metody, komerční nástroje, genetické kódy a zkratky apod. které nemají v češtině svůj název. Jsou i věty kde je víc odborných názvů než ostatních slov. Laikovi by stejně takový překlad nic neřekl, a profesionál si ho přečte přímo v angličtině.
Já třeba náměty pro zajímavý článek raději hledám v odborných médiích určených pro širší veřejnost, než přímo z vědeckých publikací.

Re: PubMed

PříspěvekNapsal: 09 lis 2015 22:42
od Petr75
No tak to uznávám :) dat moc a ještě v ang.
Přesun do jiné části, tady to fakt nemá co dělat. Dodělám postupně celý listopad.

Re: PubMed

PříspěvekNapsal: 09 lis 2015 22:51
od Franta
Jestli máš čas to překládat do češtiny, tak to klobouk dolu :)

Re: PubMed

PříspěvekNapsal: 10 lis 2015 00:12
od vychodocech
Teda Petře, je to super, tolik informací! Fakt, klobouk dolů, je to pěkný, přehledně, dobrý..... Skoro by si to zasloužilo dát do tabulky a někam dopředu, možná částečně přeložit, ale je to dost práce.. Díky Petře

Re: PubMed

PříspěvekNapsal: 10 lis 2015 19:56
od Petr75
2015 Listopad 10

1. Sclerosis multiplex stroke jellegű tünetekkel: kihívó diagnózis egy eset kapcsán.
Văcăraș V, Major ZZ, Mariș E, Major KA, Buzoianu AD.
Orv Hetil. 2015 Sep;156(37):1514-1518. Hungarian.
PMID: 26552028 [PubMed - as supplied by publisher]

2. Association Between Glutamate Blockade and Fatigue in Patients With Multiple Sclerosis.
Nourbakhsh B, Revirajan N, Waubant E.
JAMA Neurol. 2015 Nov 1;72(11):1374-1375. doi: 10.1001/jamaneurol.2015.2332. No abstract available.
PMID: 26551959 [PubMed - as supplied by publisher]

3. Curbing Inflammation in Multiple Sclerosis and Endometriosis: Should Mast Cells Be Targeted?
Hart DA.
Int J Inflam. 2015;2015:452095. doi: 10.1155/2015/452095. Epub 2015 Oct 15. Review.
PMID: 26550518 [PubMed] Cz ... edit-text=

4. Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance.
Longbrake EE, Naismith RT, Parks BJ, Wu GF, Cross AH.
Mult Scler J Exp Transl Clin. 2015 Jan-Dec;1. pii: 2055217315596994. Epub 2015 Jul 31.
PMID: 26550483 [PubMed]

5. Lower serum bilirubin concentration in patients with migraine.
Cao L, Xue L, Luo DM.
Int J Clin Exp Med. 2015 Aug 15;8(8):13398-402. eCollection 2015.
PMID: 26550273 [PubMed] Cz ... edit-text=

6. Genome-wide DNA methylation profiling of CD8+ T cells shows a distinct epigenetic signature to CD4+ T cells in multiple sclerosis patients.
Maltby VE, Graves MC, Lea RA, Benton MC, Sanders KA, Tajouri L, Scott RJ, Lechner-Scott J.
Clin Epigenetics. 2015 Nov 5;7:118. doi: 10.1186/s13148-015-0152-7. eCollection 2015.
PMID: 26550040 [PubMed]

7. Promotion of Remyelination by Sulfasalazine in a Transgenic Zebrafish Model of Demyelination.
Kim S, Lee YI, Chang KY, Lee DW, Cho SC, Ha YW, Na JE, Rhyu IJ, Park SC, Park HC.
Mol Cells. 2015 Nov 6. doi: 10.14348/molcells.2015.0246. [Epub ahead of print]
PMID: 26549504 [PubMed - as supplied by publisher] Cz ... edit-text=


8. Examination of the Chicago Multiscale Depression Inventory and Initial Validation of a Positive Scale.
Ukueberuwa DM, Arnett PA.
J Int Neuropsychol Soc. 2015 Nov 9:1-7. [Epub ahead of print]
PMID: 26548955 [PubMed - as supplied by publisher]

9. 1,8-Naphthyridine Derivatives: A Review of Multiple Biological Activities.
Madaan A, Verma R, Kumar V, Singh AT, Jain SK, Jaggi M.
Arch Pharm (Weinheim). 2015 Nov 9. doi: 10.1002/ardp.201500237. [Epub ahead of print] Review.
PMID: 26548568 [PubMed - as supplied by publisher]

10. [Magnetic resonance imaging of the brain in the monitoring of immune therapy of multiple sclerosis].
Elovaara I, Soilu-Hänninen M, Kuusisto H, Martola J, Tienari P, Färkkilä M, Remes AM.
Duodecim. 2015;131(17):1571-80. Finnish.
PMID: 26548104 [PubMed - in process]

12. Thyroid papillary carcinoma after alemtuzumab therapy for MS.
Ibitoye R, Wilkins A.
J Neurol. 2014 Sep;261(9):1828-9. doi: 10.1007/s00415-014-7453-1. Epub 2014 Aug 1. No abstract available.
PMID: 25082630 [PubMed - indexed for MEDLINE]
Similar articles
13. Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study.
Arnold DL, Gold R, Kappos L, Bar-Or A, Giovannoni G, Selmaj K, Yang M, Zhang R, Stephan M, Sheikh SI, Dawson KT.
J Neurol. 2014 Sep;261(9):1794-802. doi: 10.1007/s00415-014-7412-x. Epub 2014 Jul 3.
PMID: 24989666 [PubMed - indexed for MEDLINE] Free PMC Article
Similar articles Cz ... edit-text=

Re: PubMed

PříspěvekNapsal: 10 lis 2015 20:05
od Petr75
Dodám surová data, něco zvýrazním, něco doplním. Podle času. ;)

Re: PubMed

PříspěvekNapsal: 11 lis 2015 15:21
od Petr75
2015 Listopad 11

PubMed Results
Items 1 - 11 of 11

1. The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
[No authors listed]
Neurology. 2015 Nov 10;85(19):1728. doi: 10.1212/WNL.0000000000002113. No abstract available.
PMID: 26553944 [PubMed - in process]

2. The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
Tischner JR, Hartung DM, Bourdette DN, Whitham RH, Rittenhouse BE, Hartung DM, Bourdette DN, Ahmed S, Whitham RH.
Neurology. 2015 Nov 10;85(19):1727-8. doi: 10.1212/WNL.0000000000002095. No abstract available.
PMID: 26553943 [PubMed - in process]

3. Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial.
McKee JB, Elston J, Evangelou N, Gerry S, Fugger L, Kennard C, Kong Y, Palace J, Craner M.
BMJ Open. 2015 Nov 9;5(11):e009200. doi: 10.1136/bmjopen-2015-009200.
PMID: 26553836 [PubMed - in process]

4. Changes in brain functional connectivity patterns are driven by an individual lesion in MS: a resting-state fMRI study.
Droby A, Yuen KS, Muthuraman M, Reitz SC, Fleischer V, Klein J, Gracien RM, Ziemann U, Deichmann R, Zipp F, Groppa S.
Brain Imaging Behav. 2015 Nov 9. [Epub ahead of print]
PMID: 26553579 [PubMed - as supplied by publisher]

5. Accuracy and reaction time in recognition of facial emotions in people with multiple sclerosis.
Parada-Fernandez P, Oliva-Macias M, Amayra I, Lopez-Paz JF, Lazaro E, Martinez O, Jometon A, Berrocoso S, Garcia de Salazar H, Perez M.
Rev Neurol. 2015 Nov 16;61(10):433-440. Spanish, English.
PMID: 26553173 [PubMed - as supplied by publisher]

6. Angiopoietin -1 a C16 peptid zmírní cévní a zánětlivé reakce u EAE
Angiopoietin-1 and C16 Peptide Attenuate Vascular and Inflammatory Responses in Experimental Allergic Encephalomyelitis.
Wang B, Tian KW, Zhang F, Jiang H, Han S.
CNS Neurol Disord Drug Targets. 2015 Nov 10. [Epub ahead of print]
PMID: 26553158 [PubMed - as supplied by publisher]

7. Remyelination of the Corpus Callosum by Olfactory Ensheathing Cell in an Experimental Model of Multiple Sclerosis.
Azimi Alamouti M, Bakhtiyari M, Moradi F, Mokhtari T, Hedayatpour A, Zafari F, Barbarestani M.
Acta Med Iran. 2015 Sep;53(9):533-9.
PMID: 26553080 [PubMed - in process]

8. Protein-based classifier to predict conversion from clinically isolated syndrome to multiple sclerosis.
Borràs E, Cantó E, Choi M, Villar LM, Álvarez-Cermeño JC, Chiva C, Montalban X, Vitek O, Comabella M, Sabidó E.
Mol Cell Proteomics. 2015 Nov 9. pii: mcp.M115.053256. [Epub ahead of print]
PMID: 26552840 [PubMed - as supplied by publisher]

9. Impaired growth of the cerebellum in pediatric-onset acquired CNS demyelinating disease.
Weier K, Fonov V, Aubert-Broche B, Arnold DL, Banwell B, Collins DL.
Mult Scler. 2015 Nov 9. pii: 1352458515615224. [Epub ahead of print]
PMID: 26552732 [PubMed - as supplied by publisher]

10. Optimal detection of infratentorial lesions with a combined dual-echo MRI sequence: "PT2".
Gaitán MI, Yañes P, Sati P, Romero C, Reich DS, Correale J.
Mult Scler. 2015 Nov 9. pii: 1352458515615226. [Epub ahead of print]
PMID: 26552729 [PubMed - as supplied by publisher]

11. Long-term benefits of induction therapy in NMO: a case report.
Frau J, Coghe G, Lorefice L, Fenu G, Cocco E.
Neurol Sci. 2014 Nov;35(11):1831-2. doi: 10.1007/s10072-014-1830-5. Epub 2014 May 18. No abstract available.
PMID: 24838612 [PubMed - indexed for MEDLINE]
Similar articles

Re: PubMed

PříspěvekNapsal: 12 lis 2015 13:23
od Petr75
2015 Listopad 12
PubMed Results
Items 1 - 18 of 18

1. Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment.
Faissner S, Hoepner R, Lukas C, Chan A, Gold R, Ellrichmann G.
Ther Adv Neurol Disord. 2015 Sep;8(5):233-8. doi: 10.1177/1756285615594575. Review.
PMID: 26557898 [PubMed]

2. Optimizing the initial choice and timing of therapy in relapsing-remitting multiple sclerosis.
Farber RS, Sand IK.
Ther Adv Neurol Disord. 2015 Sep;8(5):212-32. doi: 10.1177/1756285615598910. Review.
PMID: 26557897 [PubMed]

3. The effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis.
Tsivgoulis G, Katsanos AH, Grigoriadis N, Hadjigeorgiou GM, Heliopoulos I, Papathanasopoulos P, Dardiotis E, Kilidireas C, Voumvourakis K; HELANI (Hellenic Academy of Neuroimmunology).
Ther Adv Neurol Disord. 2015 Sep;8(5):193-202. doi: 10.1177/1756285615600381.
PMID: 26557896 [PubMed]

4. Familial syndromes associated with neuroendocrine tumours.
Gut P, Komarowska H, Czarnywojtek A, Waligórska-Stachura J, Bączyk M, Ziemnicka K, Fischbach J, Wrotkowska E, Ruchała M.
Contemp Oncol (Pozn). 2015;19(3):176-83. doi: 10.5114/wo.2015.52710. Epub 2015 Jul 8. Review.
PMID: 26557756 [PubMed]

5. The Non-Obese Diabetic Mouse Strain as a Model to Study CD8(+) T Cell Function in Relapsing and Progressive Multiple Sclerosis.
Ignatius Arokia Doss PM, Roy AP, Wang A, Anderson AC, Rangachari M.
Front Immunol. 2015 Oct 22;6:541. doi: 10.3389/fimmu.2015.00541. eCollection 2015. Review.
PMID: 26557120 [PubMed]

6. Blockade of B-cell activating factor with TACI-IgG effectively reduced Th1 and Th17 cells but not memory T cells in experimental allergic encephalomyelitis mice.
Wang X, Xiao H, Wei Y, Liu X, Han G, Chen G, Hou C, Shen B, Li Y, Wang R.
Cent Eur J Immunol. 2015;40(2):142-8. doi: 10.5114/ceji.2015.52826. Epub 2015 Aug 3.
PMID: 26557026 [PubMed]

7. Comparison of Intelligibility Measures for Adults with Parkinson's Disease, Multiple Sclerosis and Healthy Controls.
Stipancic KL, Tjaden K, Wilding G.
J Speech Lang Hear Res. 2015 Nov 9. doi: 10.1044/2015_JSLHR-S-15-0271. [Epub ahead of print]
PMID: 26556727 [PubMed - as supplied by publisher]



10. ["Time is brain" in relapsing remitting multiple sclerosis : Current treatment concepts in immunotherapy].
Linker R, Kallmann BA, Kleinschnitz C, Rieckmann P, Mäurer M, Schwab S.
Nervenarzt. 2015 Nov 12. [Epub ahead of print] German.
PMID: 26556094 [PubMed - as supplied by publisher]

11. Comparative Neuroregenerative Effects of C-Phycocyanin and IFN-Beta in a Model of Multiple Sclerosis in Mice.
Pentón-Rol G, Lagumersindez-Denis N, Muzio L, Bergami A, Furlan R, Fernández-Massó JR, Nazabal-Galvez M, Llópiz-Arzuaga A, Herrera-Rolo T, Veliz-Rodriguez T, Polentarutti N, Marín-Prida J, Raíces-Cruz I, Valenzuela-Silva C, Teixeira MM, Pentón-Arias E.
J Neuroimmune Pharmacol. 2015 Nov 10. [Epub ahead of print]
PMID: 26556034 [PubMed - as supplied by publisher]


13. Undiagnosed neurological disease as a potential cause of male lower urinary tract symptoms.
Wei DY, Drake MJ.
Curr Opin Urol. 2015 Nov 9. [Epub ahead of print]
PMID: 26555692 [PubMed - as supplied by publisher]

14. Psychiatric disorders in patients with multiple sclerosis.
de Cerqueira AC, Semionato de Andrade P, Godoy Barreiros JM, Teixeira AL, Nardi AE.
Compr Psychiatry. 2015 Nov;63:10-4. doi: 10.1016/j.comppsych.2015.08.001. Epub 2015 Aug 5.
PMID: 26555486 [PubMed - in process]


16. Comparing individual and group intervention for psychological adjustment in people with multiple sclerosis: A feasibility randomised controlled trial.
das Nair R, Kontou E, Smale K, Barker A, Lincoln NB.
Clin Rehabil. 2015 Nov 9. pii: 0269215515616446. [Epub ahead of print]
PMID: 26555330 [PubMed - as supplied by publisher]

17. Deciphering Depressive Mood in Relapsing-Remitting and Progressive Multiple Sclerosis and Its Consequence on Quality of Life.
Lamargue Hamel D, Deloire M, Ruet A, Charré-Morin J, Saubusse A, Ouallet JC, Brochet B.
PLoS One. 2015 Nov 10;10(11):e0142152. doi: 10.1371/journal.pone.0142152. eCollection 2015.
PMID: 26555230 [PubMed - as supplied by publisher]

18. Detection of mycobacterium avium subsp. paratuberculosis in cheeses from small ruminants in Tuscany.
Galiero A, Fratini F, Mataragka A, Turchi B, Nuvoloni R, Ikonomopoulos J, Cerri D.
Int J Food Microbiol. 2015 Oct 31;217:195-199. doi: 10.1016/j.ijfoodmicro.2015.10.029. [Epub ahead of print]
PMID: 26555160 [PubMed - as supplied by publisher]